SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2005
OR
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number: 000-50460
TESSERA TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 16-1620029 | |
| (State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
| 3099 Orchard Drive, San Jose, California | 95134 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
(408) 894-0700
(Registrants Telephone Number, Including Area Code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨.
Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes x No ¨.
As of May 9, 2005, 43,919,392 shares of the registrants common stock were outstanding.
FORM 10-Q QUARTERLY REPORT
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2005
TABLE OF CONTENTS
| Page | ||||
| PART I | ||||
| Item 1. |
Financial Statements | |||
| Condensed Consolidated Balance Sheets (unaudited) March 31, 2005 and December 31, 2004 |
3 | |||
| 4 | ||||
| 5 | ||||
| Notes to Condensed Consolidated Financial Statements (unaudited) |
6 | |||
| Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations | 13 | ||
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risks | 23 | ||
| Item 4. |
Controls and Procedures | 23 | ||
| PART II | ||||
| Item 1. |
Legal Proceedings | 24 | ||
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds | 24 | ||
| Item 3. |
Defaults Upon Senior Securities | 24 | ||
| Item 4. |
Submission of Matters to a Vote of Security Holders | 24 | ||
| Item 5. |
Other Information | 24 | ||
| Item 6. |
Exhibits | 25 | ||
| 26 | ||||
| 27 | ||||
2
PART I FINANCIAL INFORMATION
TESSERA TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except for share amounts)
(unaudited)
| March 31, 2005 |
December 31, 2004 |
|||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 127,127 | $ | 108,339 | ||||
| Accounts receivable |
4,781 | 3,263 | ||||||
| Other current assets |
12,087 | 16,475 | ||||||
| Total current assets |
143,995 | 128,077 | ||||||
| Property and equipment, net |
3,345 | 2,484 | ||||||
| Other assets |
9,139 | 9,121 | ||||||
| Total assets |
$ | 156,479 | $ | 139,682 | ||||
| LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 1,360 | $ | 984 | ||||
| Accrued liabilities |
2,942 | 3,615 | ||||||
| Deferred revenue |
55 | 107 | ||||||
| Total current liabilities |
4,357 | 4,706 | ||||||
| Commitments and contingencies (Note 6) |
||||||||
| Stockholders equity: |
||||||||
| Common stock: $0.001 par value; 150,021,000 shares authorized; 43,490,811 and 42,145,269 shares issued and outstanding |
43 | 42 | ||||||
| Additional paid-in capital |
172,671 | 167,359 | ||||||
| Deferred stock-based compensation |
(524 | ) | (414 | ) | ||||
| Accumulated deficit |
(20,068 | ) | (32,011 | ) | ||||
| Total stockholders equity |
152,122 | 134,976 | ||||||
| Total liabilities and stockholders equity |
$ | 156,479 | $ | 139,682 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
TESSERA TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
| Three Months Ended March 31, | ||||||
| |
2005 |
|
2004 | |||
| Revenues: |
||||||
| Intellectual property revenues |
$ | 11,833 | $ | 8,896 | ||
| Other intellectual property revenues |
12,310 | 1,974 | ||||
| Service revenues |
3,756 | 2,251 | ||||
| Total revenues |
27,899 | 13,121 | ||||
| Operating expenses: |
||||||
| Cost of revenues |
2,963 | 1,850 | ||||
| Research and development (1) |
1,505 | 2,221 | ||||
| Selling, general and administrative (1) |
5,164 | 4,212 | ||||
| Stock-based compensation |
134 | 125 | ||||
| Total operating expenses |
9,766 | 8,408 | ||||
| Operating income |
18,133 | 4,713 | ||||
| Other income, net: |
||||||
| Other |
587 | 109 | ||||
| Total other income, net |
587 | 109 | ||||
| Income before taxes |
18,720 | 4,822 | ||||
| Provision for income taxes |
6,777 | 723 | ||||
| Net income |
$ | 11,943 | $ | 4,099 | ||
| Basic and diluted net income per share: |
||||||
| Net income per share; basic |
$ | 0.28 | $ | 0.11 | ||
| Net income per share; diluted |
$ | 0.25 | $ | 0.09 | ||
| Weighted average number of shares used in per share calculations; basic |
42,873 | 38,465 | ||||
| Weighted average number of shares used in per share calculations; diluted |
47,689 | 45,904 | ||||
(1) Operating expense line item detail excludes stock-based compensation, as follows: |
||||||
| Research and development |
$ | 24 | $ | 31 | ||
| Selling, general and administrative |
110 | 94 | ||||
| Total |
$ | 134 | $ | 125 | ||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
TESSERA TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
| Three Months Ended March 31, |
||||||||
| 2005 |
2004 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net income |
$ | 11,943 | $ | 4,099 | ||||
| Adjustments to reconcile income to net cash provided by operating activities: |
||||||||
| Depreciation and amortization |
279 | 231 | ||||||
| Stock-based compensation, net |
134 | 125 | ||||||
| Tax benefits from stock options |
| 70 | ||||||
| Changes in operating assets and liabilities: |
||||||||
| Accounts receivable |
(1,518 | ) | (1,072 | ) | ||||
| Other assets |
4,370 | (9 | ) | |||||
| Accounts payable |
376 | 535 | ||||||
| Accrued liabilities |
(673 | ) | 30 | |||||
| Deferred revenue |
(52 | ) | (120 | ) | ||||
| Net cash provided by operating activities |
14,859 | 3,889 | ||||||
| Cash flows from investing activities: |
||||||||
| Purchases of property and equipment |
(1,140 | ) | (310 | ) | ||||
| Net cash used in investing activities |
(1,140 | ) | (310 | ) | ||||
| Cash flows from financing activities: |
||||||||
| Proceeds from exercise of stock options and warrants, net |
4,493 | 22 | ||||||
| Proceeds from employee stock purchase program |
576 | | ||||||
| Net cash provided by financing activities |
5,069 | 22 | ||||||
| Net increase in cash and cash equivalents |
18,788 | 3,601 | ||||||
| Cash and cash equivalents at beginning of period |
108,339 | 64,379 | ||||||
| Cash and cash equivalents at end of period |
$ | 127,127 | $ | 67,980 | ||||
| Supplemental disclosure of non-cash investing and financing activities: |
||||||||
| Deferred stock-based compensation |
$ | 237 | $ | | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
TESSERA TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MARCH 31, 2005 AND MARCH 31, 2004
(unaudited)
NOTE 1 THE COMPANY AND BASIS OF PRESENTATION
Tessera Technologies, Inc. (together with its subsidiaries, Tessera, Inc. and Tessera Global, Ltd., herein referred to as Tessera or the Company) develops semiconductor packaging technology that meets the demand for miniaturization and increased performance of electronic products. The Company licenses its technology to its customers, enabling them to produce semiconductors that are smaller and faster, and incorporate more features. These semiconductors are utilized in a broad range of electronics products including digital cameras, MP3 players, personal computers, personal digital assistants, video game consoles and wireless phones.
Tessera was first incorporated in the state of Delaware in May 1990, as the entity Tessera, Inc. Tessera, Inc. was formed to develop Tesseras proprietary semiconductor packaging technology and to promote the adoption of this technology in the semiconductor industry. In January 2003, in a corporate reorganization, each outstanding share of each class and series of Tessera Inc.s capital stock was converted into a share of equivalent class and series of Tessera Technologies, Inc., a newly-formed Delaware corporation. Consequently, Tessera, Inc. became a wholly-owned subsidiary of Tessera Technologies, Inc. Tessera Technologies, Inc. is a non-operating holding company that has no assets other than its shares in Tessera, Inc. The financial position, results of operations and cash flows of Tessera, Inc. are the same as that of Tessera Technologies, Inc. when consolidated with Tessera, Inc. Since this was a reorganization of entities under common control, the financial statements are presented as if Tessera Technologies, Inc. was in existence for all periods presented. In July 2004, Tessera Global, Ltd. was incorporated in Jersey as a subsidiary of Tessera Technologies, Inc. and was formed to license semiconductor packaging technology.
The accompanying interim unaudited condensed consolidated financial statements as of March 31, 2005 and 2004 and for the three months then ended have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (SEC). The amounts as of December 31, 2004 have been derived from the Companys annual audited financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company and its results of operations and cash flows as of and for the periods presented. These financial statements should be read in conjunction with the annual audited financial statements and notes thereto as of and for the year ended December 31, 2004, included in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2004.
The results of operations for the three months ended March 31, 2005 are not necessarily indicative of the results that may be expected for the year ending December 31, 2005 or any future period and the Company makes no representations related thereto.
The Companys fiscal year ends on December 31. For quarterly reporting, the Company employs a 4-week, 4-week, 5-week reporting period. The current three-month period ended on Sunday, April 3, 2005. For presentation purposes, the financial statements and notes have been presented as ending on the last day of the nearest calendar month.
Principles of consolidation
The condensed consolidated financial statements include the accounts of Tessera Technologies, Inc. and its wholly owned subsidiaries, Tessera, Inc. and Tessera Global, Ltd. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash and cash equivalents
The Company considers all highly liquid investments with an maturity of three months or less from the date of purchase to be cash equivalents.
Fair value of financial instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying amounts for cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities approximate their respective fair values because of the short-term maturity of these items.
Concentration of credit risk
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash equivalents and accounts receivable.
The Company invests primarily in money market funds and high quality commercial paper instruments. Cash equivalents are maintained with high quality institutions, the composition and maturities of which are regularly monitored by management. The Company believes that the concentration of credit risk in its trade receivables is substantially mitigated by the Companys evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing credit evaluations of its customers financial condition and limits the amount of credit extended when deemed necessary but generally requires no collateral.
6
The following table sets forth sales to customers comprising 10% or more of the Companys total revenues for the periods indicated:
| Three Months Ended March 31, |
||||||
| 2005 |
2004 |
|||||
| Customer |
||||||
| Texas Instruments, Inc |
15 | % | 28 | % | ||
| Samsung Electronics |
36 | % | | |||
| Intel Corporation |
6 | % | 13 | % | ||
| Fujitsu Limited |
14 | % | | |||
The Companys accounts receivable are concentrated with three customers at March 31, 2005, representing 47%, 33% and 12% of aggregate gross receivables, and two customers at December 31, 2004, representing 41% and 16% of aggregate gross receivables.
Revenue recognition
The Company accounts for its revenues under the provisions of Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition. Under the provisions of SAB No. 104, the Company recognizes revenues when there is persuasive evidence of an arrangement, delivery has occurred, the fee is fixed and determinable, and collectibility of the resulting receivable is reasonably assured.
Intellectual property revenues
Intellectual property revenues include revenues from license fees and from royalty payments. Licensees typically pay a non-refundable license fee. Revenues from license fees are generally recognized at the time the license agreement is executed by both parties. In some instances, the Company provides training to its licensees under the terms of the license agreement. The amount of training provided is limited and is incidental to the licensed technology. Accordingly, in instances where training is provided under the terms of a license agreement, a portion of the license fee is deferred until such training has been provided. The amount of revenues deferred is the estimated fair value of the services, which is based on the price the Company charges for similar services when they are sold separately. These revenues are reported as service revenues. Semiconductor manufacturers and assemblers pay on-going royalties on their shipment of semiconductors incorporating the Companys intellectual property. Royalties under the Companys royalty-based technology licenses are generally based upon either unit volumes of semiconductors shipped using the Companys technology or a percent of the net sales price. Licensees generally report shipment information 30 to 60 days after the end of the quarter in which such activity takes place. As there is no reliable basis on which the Company can estimate its royalty revenues prior to obtaining these reports from the licensees, the Company recognizes royalty revenues on a one-quarter lag.
Other intellectual property revenues
Other intellectual property revenues are royalty payments received through license negotiations or the resolution of patent disputes. Such negotiations arise when it comes to the Companys attention that a third party is infringing on patents or a current licensee is not paying to the Company royalties to which it is entitled. Other intellectual property revenues represent the portion of royalty payments received through such license negotiations or resolution of patent disputes that relates to previous periods and are based on historical production volumes.
Revenues are recognized upon execution of the agreement by both parties, provided that the amounts are fixed or determinable, there are no significant Company obligations and collection is reasonably assured. The Company does not recognize any revenues prior to execution of the agreement as there is no reliable basis on which the Company can estimate the amounts for royalties related to previous periods or assess collectibility.
Service revenues
The Company utilizes the completed-contract and the percentage-of-completion methods of accounting for both commercial and government contracts, dependent upon the type of the contract. The completed-contract method of accounting is used for fixed-fee contracts with relatively short delivery times. Revenues from fixed-fee contracts are recognized upon acceptance by the customer or in accordance to the contract specifications, assuming: title and risk of loss has transferred to the customer; prices are fixed and determinable; no significant Company obligations remain; and collection of the related receivable is reasonably assured.
The Company uses the percentage-of-completion method of accounting for cost reimbursement-type contracts, which generally specify the reimbursable costs and a certain billable fee amount. Under the percentage-of-completion method, revenues recognized are that portion of the total contract price equal to the ratio of costs expended to date to the anticipated final total costs based on current estimates of the costs to complete the projects. If the total estimated costs to complete a project were to exceed the total contract amount, indicating a loss, the entire anticipated loss would be recognized immediately. Revenues, including estimated earned fees, under cost reimbursement-type contracts are recognized as costs are incurred, assuming that the fee is fixed or determinable and collection is reasonably assured.
Claims made for amounts in excess of the agreed contract price are recognized only if it is probable that the claim will result in additional revenue and the amount of additional revenue can be reliably estimated.
Research and development costs
Research and development costs consist primarily of compensation and related costs for personnel as well as costs related to patent prosecution, materials, supplies and equipment depreciation. All research and development costs are expensed as incurred.
Income taxes
The Company accounts for its income taxes under the liability method. Under this method, deferred tax assets and liabilities are determined on the basis of the difference between income tax bases of assets and liabilities and their respective financial reporting amounts at enacted tax rates in effect for the periods in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to their realizable value when management cannot conclude based on available objective evidence that it is more likely than not that the benefit will be realized for the deferred tax assets.
7
Indemnification
The Company does not have guarantees required to be disclosed under Financial Accounting Standards Board Interpretation (FIN) No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others. However, some of the Companys technology license agreements provide certain types of indemnification for customers regarding intellectual property infringement claims. Also, the Company indemnifies its officers and directors under the terms of indemnity agreements entered into with them, as well as pursuant to its certificate of incorporation, bylaws and applicable Delaware law. As of March 31, 2005, no such claims have been filed against the Company, and no liability has been accrued.
Stock-based compensation
The Companys employee stock option plans are accounted for in accordance with Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and complies with the disclosure provisions of Financial Accounting Standards Board (FASB) Statement No. 123, Accounting for Stock-Based Compensation (Statement 123) and FASB Statement No. 148, Accounting for Stock-Based Compensation, Transition and Disclosure.
The Company accounts for stock issued to non-employees in accordance with the provisions of Statement 123 and Emerging Issues Task Force Consensus (EITF) No. 96-18, Accounting for Equity Instruments That are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services. Under Statement 123 and EITF No. 96-18, stock option awards issued to non-employees are accounted for at fair value using the Black-Scholes option-pricing model. The Company believes that the fair value of the stock options are more reliably measured than the fair value of the services received. The fair value of each non-employee stock award is re-measured at each reporting date until a commitment date is reached, which is generally the vesting date. In connection with non-employee stock awards, the Company recorded compensation expense of $22,000 and $91,000 for the three months ended March 31, 2005 and 2004, respectively.
Expense associated with stock-based compensation is amortized on an accelerated basis over the vesting period of the individual award, consistent with the method described in Financial Accounting Standards Board Interpretation No. (FIN) 28, Accounting for Stock Appreciation Rights and Other Variable Stock Option or Award Plans, an Interpretation of APB Opinion No. 15 and 25.
The following table illustrates the effect on net income and net income per share if the Company had applied the fair value method as prescribed by Statement 123. The estimated fair value of each Company option is calculated using the Black-Scholes option-pricing model (in thousands except per share data):
| Three Months Ended March 31, |
||||||||
| |
2005 |
|
|
2004 |
| |||
| Net income - as reported |
$ | 11,943 | $ | 4,099 | ||||
| Plus: Stock-based employee compensation expense determined under APB Opinion No. 25, included in reported net income, net of tax |
4 | 34 | ||||||
| Less: Stock-based employee compensation expense determined under fair value based method, net of tax |
(3,180 | |||||||